Delivery Order SPE2DB22D3009-SPE2DB24FBB11
Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nalbuphine 100 mg/10 mL vials. The award, with a ceiling value of $2,946.07, is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $3,332.86. The contract is a Firm Fixed Price Delivery Order, with a completion date of May 30, 2025. The contract is not set aside. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.80 firm fixed-price delivery order is for the supply of 4567767272 ! NALBUPHINE 200 MG/10 ML VIAL 10ML, with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $3,498.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a performance period ending on December 20, 2024. The contract is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,036.86 for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 18, 2025, with a completion date of February 19, 2025. This contract represents a small portion of Amerisourcebergen's broader contracting relationship with the federal government, as the company...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of naloxone 0.4 mg/ml vials, a medication used to treat opioid overdose. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,917.14 and a performance period through July 3, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp also holds a larger...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,557,196,796 units of Naloxone HCL 2ML 10S, a critical pharmaceutical product, with a potential value of $10,490.35. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,213.48, is for the delivery of 4,567,754,528 units of 2 mg/2 mL naloxone syringes. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 2, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,460,825 units of 2 milligram/2 milliliter naloxone syringes. The contract has a firm-fixed price of $6,185.77 and a completion date of June 6, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the U.S. Department of Defense (DoD) Medical Supply Chain. The contract, valued at $3,032.50, is for the delivery of 1 milliliter vials of naloxone, an opioid overdose reversal medication, in packages of 10. The contract is a firm-fixed-price delivery order with an ultimate completion date of August 12, 2025. Amerisourcebergen Drug Corp...